GSK going Generic?

Discussion in 'GlaxoSmithKline' started by Anonymous, May 13, 2015 at 8:43 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    After listening to Andrew Witty explain the new, high volume strategy in the interview on CNBC, it seems to me he is basically saying that GSK plans to out-compete generic manufacturers on off-patent medicines. Is this really the most profitable way to use the talents of the company?
     

  2. Anonymous

    Anonymous Guest

    I am pretty sure that now all the real talent has left GSK the remaining gender and diversity ass clowns that are left probably couldn't even sell a $4 generic.
     
  3. Anonymous

    Anonymous Guest

    AW is either a liar or a bit dim.
    five years ago he was boasting about his pipeline and how LLY or AZN would need to be acquired to survive
    three years ago he was boasting about others falling over the patent cliff while GSK had already emerged on the brighter side
    two years ago he was boasting about pharma launches in respiratory, oncology and vaccines
    last year he was boasting about growth excluding supply chain issues
    Always boasting about GSK's superior values and new selling strategy

    results
    We've lost credibility in Pharma and would be happy to be acquired by LLY/AZN/PFE
    We're now realizing the patent cliff is ahead not behind us
    Our pipeline has been a huge and expensive dud while our acquisitions have failed
    Supply chain issues were caused by AW's lack of understanding and fear. This has continued in 2015 and will defeat the "volume growth" strategy AW has touted.
    GSK doesn't play by the rules and has been outed in China and will be outed in a host of other markets (just the beginning).
     
  4. Anonymous

    Anonymous Guest

    Please everybody read todays Forbes online. It talks about Sir Andrew leading GSK. Not a great vote of confidence.
     
  5. Anonymous

    Anonymous Guest

    Generics is the only way out of our mess. Pfizer is gonna buy our ass cheap.